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Abstract 
Synchronous endometrial and cervical can-
cer  is  a  very  rare  condition.  This  report
describes a case of a 46-year-old woman who
presented with a cervical mass that measured
5.6 cm along its longest diameter, whose biop-
sy  analysis  revealed  an  endocervical  muci-
nous adenocarcinoma. She was classified as
having an IB2 cervical carcinoma and treated
with  concurrent  chemoradiation  plus  hys-
terectomy.  Pathological  and  immunohisto-
chemical analysis of the surgical specimens
revealed a synchronous endometrioid grade 2
adenocarcinoma in the endometrium, and a
well-differentiated  mucinous  adenocarcino-
ma in the cervix. Magnetic resonance imag-
ing (MRI) studies performed prior to treat-
ment were reviewed and apparent diffusion
coefficient (ADC) maps were generated. The
ADC  values  demonstrated  distinct  signal
intensity differences between the endometri-
al and endocervical tumors. In conclusion, dif-
fusion-weighted MRI and ADC maps can help
to distinguish the site of origin of synchro-
nous tumors.
Introduction
Synchronous endometrial and cervical can-
cer is a very rare condition, which generally
presents  as  an  adenocarcinoma  in  the
endometrium and a squamous cell carcinoma
in the cervix.1-4 Even rarer is the occurrence of
adenocarcinoma of the uterine cervix associat-
ed  with  an  endometrial  adenocarcinoma.5,6
The distinction between cervical and endome-
trial  adenocarcinomas  can  be  very  difficult
because  of  overlapping  morphological  fea-
tures.7-9
Diffusion-weighted  imaging  (DWI)  is  a
technique used to show tissue characteristics
based on the diffusion motion of water mole-
cules that is known as Brownian motion.10 DW
imaging can also provide quantitative meas-
urement  of  apparent  diffusion  coefficient
(ADC) value, which is considered to be influ-
enced by cellular density in solid tissues.11 The
ADC is an indicator of the movement of water
within  the  tissue.  Decreased  ADC  values  in
malignant tumors compared with normal tis-
sues or benign lesions have been previously
reported in various organs.12
DWI for uterine cervical cancer and ADC val-
ues of cervical cancer differ from those of the
normal cervix, and could be used to indicate
the histological type and the pathological grade
of tumor.13 Furthermore, it could distinguish
between most uterine adenocarcinomas origi-
nating from the cervix and endometrium.14 To
the  best  of  our  knowledge,  this  is  the  first
report of a synchronous endometrial and endo-
cervical adenocarcinoma analyzed by DWI and
ADC values. 
Case Report
A  46-year-old  woman  presented  with  a  3-
month history of vaginal bleeding during inter-
course. A gynecological examination revealed
a  cervical  mass  measuring  5.6  cm  along  its
longest diameter. Biopsy analysis revealed an
endocervical  adenocarcinoma,  histological
grade  1  (Figure  1A).  It  was  staged  as  IB2,
according  to  guidelines  of  the  International
Federation  of  Gynecology  and  Obstetrics
(FIGO).15
The patient underwent concurrent chemora-
diation  followed  by  a  simple  hysterectomy.
Pathological analysis of the surgical specimen
revealed  residual  tumor  involving  only  the
body  of  the  uterus.  The  residual  tumor  was
classified as a grade 2 endometrioid adenocar-
cinoma, which was positive for estrogen and
progesterone receptors and vimentin (Figure
1B).  The  endometrial  tumor  infiltrated  less
than 50% of the myometrium. These findings
were consistent with a diagnosis of synchro-
nous endometrial and endocervical adenocar-
cinoma. 
Magnetic resonance imaging (MRI) studies
performed  prior  to  the  treatment  were
reviewed.  The  ADC  maps  prior  to  treatment
were also generated. In these maps, neoplastic
tissue  was  associated  with  heterogeneous,
hypointense areas. Regions of interest were
identified  by  MRI  and  indicated  with  white
boxes within the ADC maps, and ADC values
associated  with  these  regions  were
0.72±0.18¥10-3 mm2/s  (Figure  2C)  for  the
endometrial tumor and 0.59±0.12¥10-3 mm2/s
for the cervical tumor (Figure 2C). Figures 2A
and 2B, representing the sagittal and coronal
T2-weighted  images  that  demonstrate  both
masses, were present in both the endometrial
cavity  and  the  endocervical  canal.  Each  was
associated with distinct signal intensities.
Discussion
Neoplastic involvement of the uterine body
and cervix often raises important discussions
about the primary site, as treatment options are
quite different. Preoperative diagnosis of biopsy
or  curettage  is  frequently  inconclusive.
Determining the primary site of a uterine ade-
nocarcinoma when both the uterine body and
endocervix are involved can be problematic due
to the overlapping morphology of endocervical
adenocarcinomas and endometrial carcinomas.
The hypothesis of synchronous tumors for these
two adenocarcinomas has been rarely identi-
fied, although it is possible that this event is
more common that currently estimated. 
The  majority  of  adenocarcinomas  that
involve  the  cervix  and  endometrium  have  a
similar  morphology.  Despite  many  of  these
tumors being classified as primary endometri-
al cancers that involve the cervix, or primary
cervical cancers that involve the endometrium,
at least some of these cases may be a result of
two different primary neoplasms.
To the best of our knowledge, this is the first
report of the use of MRI and ADC to differenti-
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ate synchronous endometrial and endocervical
adenocarcinomas. DWI has the potential abili-
ty to differentiate between normal and cancer-
ous  tissue  in  the  uterine  cervix,13 but  it
appears  to  be  useful  for  differentiating  syn-
chronous tumors arising from the endometri-
um and cervix. 
The differential diagnosis between primary
endometrial or endocervical cancer is very dif-
ficult  with  routine  hematoxylin  and  eosin
staining, and even with aid of immunohisto-
chemistry (IHC). The common immunomark-
ers used to determine cell differentiation are
vimentin, carcinoembryonic antigen, estrogen
receptor, progesterone receptor and p16, but
IHC studies are often unhelpful for differenti-
ating  between  synchronous  endometrial  and
endocervical  tumors,  especially  those  of  the
endometrioid type.9
In  our  case  the  morphology  of  the  two
tumors  was  distinct  in  the  cervix  and
endometrium, being, respectively, of the endo-
cervical  and  endometrioid  histological  type,
which suggested the diagnosis of synchronous
endometrial  and  endocervical  adenocarcino-
ma, although this was initially unsuspected.
The patient was treated as a case of IB2 (FIGO)
cervical cancer and received chemoradiation
plus  laparoscopic  hysterectomy  and  bilateral
salpingo-oophorectomy  as  this  was  a  bulky
tumor. After reviewing the MRI scan performed
prior to treatment, we noted that the sagittal
and coronal T2 weighted images showed con-
current masses in the endometrial cavity and
the endocervical canal with a clear difference
in signal intensity (Figure 1A and 1B). ADC
maps (Figure 1C) showed neoplastic tissue as
heterogeneous hypointense areas. Regions of
interest placed into those areas and ADC val-
ues confirmed different patterns of ADC in the
endometrial and cervical tumors.
Conclusion
Synchronous endometrial and endocervical
adenocarcinomas  are  extremely  rare  condi-
tions.  As  adenocarcinomas  from  the
endometrium and the endocervix often pres-
ent with a significant overlap of morphological
and  immunohistochemical  features,  the  cor-
rect diagnosis can be very difficult. Moreover,
when the adenocarcinomas are located in both
the endometrial and endocervical canals, it is
very  difficult  to  determine  the  exact  site  of
tumor  origin  using  conventional  imaging
methods. DWI is a magnetic resonance tech-
nique that, at the microscopic level, can iden-
tify differences in water mobility in extracellu-
lar  spaces.  Correspondingly,  in  the  present
case, diffusion-weighted MRI and ADC maps
helped  to  distinguish  the  origin  of  both
tumors. 
Case Report
Figure 1. A) Adenocarcinoma seen in the cervical biopsy prior to treatment. Neoplasia
with  villoglandular  architecture  with  low  grade  nuclei  and  signs  of  mucin  secretion
(hematoxylin-eosin; original magnification ¥100); B) Endometrial adenocarcinoma after
treatment  showing  glandular  and  cribriform  architecture  and  intraglandular  foci  of
necrosis (hematoxylin-eosin; original magnification ¥100).
Figure 2. A,B) Sagittal and coronal T2-weighted images that demonstrate masses in both
the endometrial cavity and the endocervical canal; each is associated with distinct signal
intensities; C) apparent diffusion coefficient (ADC) maps generated prior to treatment.[Rare Tumors 2012; 4:e19] [page 63]
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